Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "oct-648"
Home
Can AI Spot At-Risk Patients Early? Hospitals Explore the Next Frontier
Can artificial intelligence detect warning signs before a patient's condition becomes critical? Can it diagnose diseases by analyzing medical images...
10/20/2026, 09:25 ET
Uterine Conditions Easy to Miss During the Menopausal Transition
Women in their 40s and 50s experience a range of physical changes as they approach menopause. Their menstrual cycles may become irregular, or the...
10/20/2026, 09:25 ET
Lung Cancer Five-Year Survival Reaches 71% for High-Income Patients but Only 37% for Low-Income Group
While advancements in lung cancer treatment have steadily boosted overall survival rates in South Korea, a substantial...
10/20/2026, 09:25 ET
American Physician, 71, Avoids Permanent Paralysis After Emergency Spinal Surgery in South Korea
A 71-year-old American physician who had long managed chronic back pain underwent emergency spinal surgery shortly...
10/20/2026, 04:09 ET
Kang Dae-hee: "Asia's Medical Infrastructure Fails to Keep Pace with Rapid Economic Growth... Telemedicine is the Answer"
“Asian economies are growing rapidly, but they are struggling to build out healthcare infrastructure.
10/19/2026, 04:09 ET
Asan Medical Center Introduces Korea’s First Transperineal Robotic Prostate Biopsy System
In prostate cancer diagnostics, minimizing procedural infection risks is as vital as accurately sampling suspicious...
10/19/2026, 04:07 ET
Can Atherosclerotic Plaque Be Reversed? New Institute Led by Professor Jang Ki-yuk Aims to Find Out
The Catholic Medical Center announced on the 12th that the Catholic Vascular Recovery Research Institute (C-RESOLVE),...
10/19/2026, 04:07 ET
Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul
What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the...
10/16/2026, 22:38 ET
Brown, White, or Animal Welfare? A Consumer's Guide to Choosing Quality Eggs
Eggs are a universal grocery staple, yet shoppers frequently pause in the dairy aisle, weighing whether brown eggs are...
10/16/2026, 22:37 ET
Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug
A domestically developed therapy has entered South Korea’s obesity treatment market, long dominated by imported...
10/16/2026, 22:37 ET
Previous
3
4
5
6
7
Next